Article de revue
Hepatitis B vaccine in healthy hospital employees
A low rate of seroconversion to hepatitis B vaccine is reported. This occurred in healthy hospital employees from two separate institutions. A total of 236 individuals were evaluated in this study and only 53% or 124 persons developed protective levels of antibody to hepatitis B surface antigen following a complete vaccine series. In one hospital, 30% of the vaccine recipients developed antibody but not to a protective level. Employees who received the entire series in the arm or in the arm and buttock (mixed) had a significantly greater number of responders than employees who received the entire series in the buttock (P less than .05). Recipients aged 50 to 59 years had a significantly lower response rate to the vaccine (P less than .05). There was no correlation with the vaccinee\'s sex or the timing of the second injection. Vaccine was noted to have frozen in one hospital and accounted for some loss of antigenicity. This failure to respond to the vaccine has necessitated the use of booster injections of vaccine and continued antibody monitoring.
Auteurs
Langues
- Anglais
Journal
Infection Control
Volume
7
Type
Article de revue
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Hépatite B
FREEZE-PREVENTION-POTENCY
Vous pouvez trouver plus d’informations sur "FREEZE-PREVENTION-POTENCY" dans les rubriques suivantes :
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Cold chain study: danger of freezing vaccines | P. Milhomme | Journal article | Anglais | |
| Hepatitis B vaccine | Arlene A. McLean, Raymond Shaw Jr. | Journal article | Anglais | |
| Hepatitis B vaccine in healthy hospital employees | R. Normand, R. Silberman, S. A. Klotz | Journal article | Anglais | |
| Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds | Ann Marie Kimball, Arslan Rinchin, J. Khulan, James S. Edstam, Nyamkhuu Dulmaa, Pagbajabyn Nymadawa | Journal article | Anglais | |
| Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus | J. Bennett, S. Cochi, F. van Loon, J. B. Milstien, V. Dietz | 1996 | Journal article | Anglais |
| Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines | Christina Ann Boros, D. M. Roberton, M. Hanlon, Michael Steven Gold | Journal article | Anglais | |
| Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles | Dvorah Diminsky, Marian Gorecki, Neomi Moav, Yechezkel Barenholz | Journal article | Anglais | |
| Effects of freezing on DPT and DPT-IPV vaccines, adsorbed | R. Dimayuga, D. Scheifele, A. Bell | 1995 | Journal article | Anglais, Français |
| Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems | V. Dietz, A. Galazka, F. van Loon, S. Cochi | 1997 | Journal article | Anglais |
| Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures | Jessica A. White, Jacqueline Fournier-Caruana, Diana Kouiavskaia, Konstantin Chumakov, William C. Weldon, Marcus Estrada, Dexiang Chen, Abhijeet Anand, Cynthia J. Snider, M. Steven Oberste, Edmond F. Maes, Howard E. Gary Jr., Eric Stevens | 2018 | Journal article | Anglais |
